Department of Biology, Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA 16802, USA.
J Evol Biol. 2011 Nov;24(11):2410-22. doi: 10.1111/j.1420-9101.2011.02369.x. Epub 2011 Aug 23.
Malaria infections normally consist of more than one clonally replicating lineage. Within-host interactions between sensitive and resistant parasites can have profound effects on the evolution of drug resistance. Here, using the Plasmodium chabaudi mouse malaria model, we ask whether the costs and benefits of resistance are affected by the number of co-infecting strains competing with a resistant clone. We found strong competitive suppression of resistant parasites in untreated infections and marked competitive release following treatment. The magnitude of competitive suppression depended on competitor identity. However, there was no overall effect of the diversity of susceptible parasites on the extent of competitive suppression or release. If these findings generalize, then transmission intensity will impact on resistance evolution because of its effect on the frequency of mixed infections, not because of its effect on the distribution of clones per host. This would greatly simplify the computational problems of adequately capturing within-host ecology in models of drug resistance evolution in malaria.
疟疾感染通常由多个无性繁殖系组成。宿主内敏感和耐药寄生虫之间的相互作用对耐药性的进化有深远的影响。在这里,我们使用伯氏疟原虫小鼠疟疾模型,来研究与耐药克隆竞争的混合感染株的数量是否会影响耐药的成本和收益。我们发现,在未治疗的感染中,耐药寄生虫受到强烈的竞争抑制,而在治疗后则受到明显的竞争释放。竞争抑制的程度取决于竞争者的身份。然而,易感寄生虫的多样性对竞争抑制或释放的程度没有总体影响。如果这些发现具有普遍性,那么由于混合感染频率对耐药性进化的影响,而不是对每个宿主中克隆分布的影响,那么传播强度将对耐药性进化产生影响。这将极大地简化疟疾耐药性进化模型中充分捕捉宿主内生态学的计算问题。